A unique melanocortin-4-receptor signaling profile for obesity-associated constitutively active variants.

GPCR signaling profile constitutive GPCR constitutive activity intracellular GPCR signaling melanocortin-4 receptor obesity

Journal

Journal of molecular endocrinology
ISSN: 1479-6813
Titre abrégé: J Mol Endocrinol
Pays: England
ID NLM: 8902617

Informations de publication

Date de publication:
01 07 2023
Historique:
received: 08 03 2023
accepted: 11 04 2023
medline: 14 6 2023
pubmed: 12 4 2023
entrez: 11 4 2023
Statut: epublish

Résumé

The melanocortin-4 receptor (MC4R) plays a critical role in regulating energy homeostasis. Studies on obesogenic human MC4R (hMC4R) variants have not yet revealed how hMC4R maintains body weight. Here, we identified a signaling profile for obesogenic constitutively active H76R and L250Q hMC4R variants transfected in HEK293 cells that included constitutive activity for adenylyl cyclase (AC), cyclic adenosine monophosphate (cAMP) response element (CRE)-driven transcription, and calcium mobilization but not phosphorylated extracellular signal-regulated kinase 1/2 (pERK1/2) activity. Importantly, the signaling profile included impaired α-melanocyte-stimulating hormone-induced CRE-driven transcription but not impaired α-melanocyte-stimulating hormone-induced AC, calcium, or pERK1/2. This profile was not observed for transfected H158R, a constitutively active hMC4R variant associated with overweight but not obesity. We concluded that there is potential for α-melanocyte-stimulating hormone-induced CRE-driven transcription in HEK293 cells transfected with obesogenic hMC4R variants to be the key predictive tool for determining whether they exhibit loss of function. Furthermore, in vivo, α-melanocyte-stimulating hormone-induced hMC4R CRE-driven transcription may be key for maintaining body weight.

Identifiants

pubmed: 37040537
doi: 10.1530/JME-23-0008
pii: e230008
pmc: PMC10304906
doi:
pii:

Substances chimiques

alpha-MSH 581-05-5
Calcium SY7Q814VUP
Receptor, Melanocortin, Type 4 0
Cyclic AMP E0399OZS9N
Adenylyl Cyclases EC 4.6.1.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Anal Biochem. 1999 Nov 1;275(1):54-61
pubmed: 10542109
Nat Chem Biol. 2014 Dec;10(12):1061-5
pubmed: 25362359
Int J Mol Sci. 2020 Feb 12;21(4):
pubmed: 32059383
Cell. 2019 Apr 18;177(3):597-607.e9
pubmed: 31002796
Curr Opin Cell Biol. 2014 Apr;27:109-16
pubmed: 24680436
CSH Protoc. 2008 Feb 01;2008:pdb.prot4861
pubmed: 21356760
Trends Pharmacol Sci. 2018 Oct;39(10):879-891
pubmed: 30180973
Neuron. 1990 Jul;5(1):1-10
pubmed: 2196069
Endocr Rev. 2010 Aug;31(4):506-43
pubmed: 20190196
Br J Pharmacol. 2018 Nov;175(21):4026-4035
pubmed: 28872669
J Biol Chem. 2009 Sep 25;284(39):26411-20
pubmed: 19648111
Anal Biochem. 1995 Apr 10;226(2):349-54
pubmed: 7793637
Gastroenterology. 2019 May;156(6):1600-1616
pubmed: 30771352
J Neuroendocrinol. 2019 Oct;31(10):e12795
pubmed: 31529534
Methods Enzymol. 2010;484:267-79
pubmed: 21036237
Biochim Biophys Acta. 2013 Dec;1832(12):1939-48
pubmed: 23791567
J Biol Chem. 2020 Aug 14;295(33):11626-11642
pubmed: 32571882
Sci Rep. 2016 Sep 09;6:32776
pubmed: 27612207
Adv Pharmacol. 2014;70:135-54
pubmed: 24931195
J Mol Endocrinol. 2021 Apr 26;66(4):285-297
pubmed: 33739935
Prog Mol Biol Transl Sci. 2009;88:173-204
pubmed: 20374728
Physiol Genomics. 2001 Feb 07;5(1):11-9
pubmed: 11161002
Traffic. 2019 Feb;20(2):121-129
pubmed: 30536564
Regul Pept. 2004 Aug 15;120(1-3):113-8
pubmed: 15177928
Biomolecules. 2022 Feb 02;12(2):
pubmed: 35204745
Neuron. 1997 Feb;18(2):183-6
pubmed: 9052789
Biochemistry. 2006 Jun 13;45(23):7277-88
pubmed: 16752916
Semin Immunol. 2022 Jan;59:101603
pubmed: 35341670
Sci Transl Med. 2017 May 31;9(392):
pubmed: 28566424
J Clin Invest. 2000 Jul;106(2):253-62
pubmed: 10903341
Brain Res. 2003 Oct 3;986(1-2):1-11
pubmed: 12965224
Trends Pharmacol Sci. 2018 Feb;39(2):200-208
pubmed: 29478570
J Mol Endocrinol. 2013 Mar 18;50(2):217-27
pubmed: 23307947
J Biol Chem. 2012 Jun 22;287(26):21873-90
pubmed: 22544740
PLoS One. 2015 Oct 15;10(10):e0140320
pubmed: 26469516
Obesity (Silver Spring). 2016 Sep;24(9):1976-82
pubmed: 27474872
J Physiol. 2010 Dec 15;588(Pt 24):4871-89
pubmed: 21041529
Nat Med. 2021 Jun;27(6):1088-1096
pubmed: 34045736
Chem Biol Drug Des. 2006 Mar;67(3):215-29
pubmed: 16611215
Curr Opin Cell Biol. 2016 Apr;39:53-60
pubmed: 26921695
Diabetes. 2008 Sep;57(9):2511-8
pubmed: 18559663
Cell Rep. 2021 Mar 23;34(12):108862
pubmed: 33761344
Biochemistry. 2011 Jul 12;50(27):6022-9
pubmed: 21644508
Endocrinology. 1999 May;140(5):2167-72
pubmed: 10218968
Genomics. 2002 Jun;79(6):833-43
pubmed: 12036298
Int J Biol Sci. 2014 Oct 09;10(10):1128-37
pubmed: 25332687
J Mol Endocrinol. 2013 Feb 26;50(2):203-15
pubmed: 23296982

Auteurs

Rikus Botha (R)

Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, New Zealand.

Shree S Kumar (SS)

Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, New Zealand.

Natasha L Grimsey (NL)

Department of Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, New Zealand.
Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, New Zealand.
Maurice Wilkins Centre for Biodiscovery, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, New Zealand.

Kathleen G Mountjoy (KG)

Department of Physiology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, New Zealand.
Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, New Zealand.
Maurice Wilkins Centre for Biodiscovery, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, New Zealand.
Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Private Bag, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH